Cargando…

The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial

BACKGROUND: Acne is the most common skin disorder which is known as a chronic inflammatory disease with psychological burden and reduced quality of life. Adipose tissue-derived stromal vascular fraction (SVF) is recognized as a source of regenerative cells and improves the quality of skin by increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Behrangi, Elham, Moradi, Sepideh, Ghassemi, Mohammadreza, Goodarzi, Azadeh, Hanifnia, Amirreza, Zare, Sona, Nouri, Maryam, Dehghani, Abbas, Seifadini, Azadeh, Nilforoushzadeh, Mohammad Ali, Roohaninasab, Masoumeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284502/
https://www.ncbi.nlm.nih.gov/pubmed/35841057
http://dx.doi.org/10.1186/s13287-022-02957-2
_version_ 1784747575057842176
author Behrangi, Elham
Moradi, Sepideh
Ghassemi, Mohammadreza
Goodarzi, Azadeh
Hanifnia, Amirreza
Zare, Sona
Nouri, Maryam
Dehghani, Abbas
Seifadini, Azadeh
Nilforoushzadeh, Mohammad Ali
Roohaninasab, Masoumeh
author_facet Behrangi, Elham
Moradi, Sepideh
Ghassemi, Mohammadreza
Goodarzi, Azadeh
Hanifnia, Amirreza
Zare, Sona
Nouri, Maryam
Dehghani, Abbas
Seifadini, Azadeh
Nilforoushzadeh, Mohammad Ali
Roohaninasab, Masoumeh
author_sort Behrangi, Elham
collection PubMed
description BACKGROUND: Acne is the most common skin disorder which is known as a chronic inflammatory disease with psychological burden and reduced quality of life. Adipose tissue-derived stromal vascular fraction (SVF) is recognized as a source of regenerative cells and improves the quality of skin by increasing collagen content. To date, a few studies have been performed on the therapeutic role of SVF in the treatment of acne scars. METHODS: This randomized, single-blinded clinical trial was performed on 7 patients with acne scars. In all patients, the initial grade of acne (volume, area and depth) was evaluated and ultrasound of the relevant scar was performed to evaluate neocollagenesis. As a spilt face study, for treating the scars, we used nanofat subcutaneously on one side of the face (control group) and combination of nanofat subcutaneously and SVF intradermally on the opposite side (intervention group). The patients were evaluated for severity of acne by visioface after one month, also for thickness of epidermis and dermis by ultrasound after one month and three months. RESULTS: All of the apparent findings of scars improved in two groups after one month, but these changes were significant just for the group treated with SVF (p value < 0.05). Epidermal, dermal and complete thicknesses during the first month in both control and intervention groups were significantly increased (p value < 0.05) but between the first and third months, there was no significant difference in the variables (p value > 0.05). The findings showed that dermal and complete thicknesses of the skin in the first month were different between two groups significantly (p value: 0.042 and 0.040, respectively). CONCLUSION: The use of SVF in the treatment of patients with acne scars accelerates the improvement of volume, area and depth of the scar by increasing collagen content and the dermal thickness, so it can be used as a potentially effective treatment for these patients.
format Online
Article
Text
id pubmed-9284502
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92845022022-07-15 The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial Behrangi, Elham Moradi, Sepideh Ghassemi, Mohammadreza Goodarzi, Azadeh Hanifnia, Amirreza Zare, Sona Nouri, Maryam Dehghani, Abbas Seifadini, Azadeh Nilforoushzadeh, Mohammad Ali Roohaninasab, Masoumeh Stem Cell Res Ther Research BACKGROUND: Acne is the most common skin disorder which is known as a chronic inflammatory disease with psychological burden and reduced quality of life. Adipose tissue-derived stromal vascular fraction (SVF) is recognized as a source of regenerative cells and improves the quality of skin by increasing collagen content. To date, a few studies have been performed on the therapeutic role of SVF in the treatment of acne scars. METHODS: This randomized, single-blinded clinical trial was performed on 7 patients with acne scars. In all patients, the initial grade of acne (volume, area and depth) was evaluated and ultrasound of the relevant scar was performed to evaluate neocollagenesis. As a spilt face study, for treating the scars, we used nanofat subcutaneously on one side of the face (control group) and combination of nanofat subcutaneously and SVF intradermally on the opposite side (intervention group). The patients were evaluated for severity of acne by visioface after one month, also for thickness of epidermis and dermis by ultrasound after one month and three months. RESULTS: All of the apparent findings of scars improved in two groups after one month, but these changes were significant just for the group treated with SVF (p value < 0.05). Epidermal, dermal and complete thicknesses during the first month in both control and intervention groups were significantly increased (p value < 0.05) but between the first and third months, there was no significant difference in the variables (p value > 0.05). The findings showed that dermal and complete thicknesses of the skin in the first month were different between two groups significantly (p value: 0.042 and 0.040, respectively). CONCLUSION: The use of SVF in the treatment of patients with acne scars accelerates the improvement of volume, area and depth of the scar by increasing collagen content and the dermal thickness, so it can be used as a potentially effective treatment for these patients. BioMed Central 2022-07-15 /pmc/articles/PMC9284502/ /pubmed/35841057 http://dx.doi.org/10.1186/s13287-022-02957-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Behrangi, Elham
Moradi, Sepideh
Ghassemi, Mohammadreza
Goodarzi, Azadeh
Hanifnia, Amirreza
Zare, Sona
Nouri, Maryam
Dehghani, Abbas
Seifadini, Azadeh
Nilforoushzadeh, Mohammad Ali
Roohaninasab, Masoumeh
The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial
title The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial
title_full The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial
title_fullStr The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial
title_full_unstemmed The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial
title_short The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial
title_sort investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284502/
https://www.ncbi.nlm.nih.gov/pubmed/35841057
http://dx.doi.org/10.1186/s13287-022-02957-2
work_keys_str_mv AT behrangielham theinvestigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT moradisepideh theinvestigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT ghassemimohammadreza theinvestigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT goodarziazadeh theinvestigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT hanifniaamirreza theinvestigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT zaresona theinvestigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT nourimaryam theinvestigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT dehghaniabbas theinvestigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT seifadiniazadeh theinvestigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT nilforoushzadehmohammadali theinvestigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT roohaninasabmasoumeh theinvestigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT behrangielham investigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT moradisepideh investigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT ghassemimohammadreza investigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT goodarziazadeh investigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT hanifniaamirreza investigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT zaresona investigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT nourimaryam investigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT dehghaniabbas investigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT seifadiniazadeh investigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT nilforoushzadehmohammadali investigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial
AT roohaninasabmasoumeh investigationoftheefficacyandsafetyofstromalvascularfractioninthetreatmentofnanofattreatedacnescararandomizedblindedcontrolledclinicaltrial